These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17086134)

  • 41. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the prevalence of tuberculosis infection in BCG vaccinated versus nonvaccinated school age children.
    Pulickal AS; Fernandez GV
    Indian Pediatr; 2007 May; 44(5):344-7. PubMed ID: 17536134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European survey of BCG vaccination policies and surveillance in children, 2005.
    Infuso A; Falzon D;
    Euro Surveill; 2006; 11(3):6-11. PubMed ID: 16567882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An audit of BCG immunisation and tuberculin skin testing in Scotland. Scottish BCG Study Group.
    Pell J; Capewell S
    Health Bull (Edinb); 1996 Nov; 54(6):490-4. PubMed ID: 8990615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren.
    Chee CB; Soh CH; Boudville IC; Chor SS; Wang YT
    Am J Respir Crit Care Med; 2001 Sep; 164(6):958-61. PubMed ID: 11587978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BCG vaccination and epidemiological situation: a decision making approach to the use of BCG.
    Rouillon A; Waaler H
    Adv Tuberc Res; 1976; 19():64-126. PubMed ID: 970278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [BCG vaccination coverage in children born after the end of compulsory BCG vaccination and followed in maternal and child health clinics in France: a national survey 2009].
    Guthmann JP; Fonteneau L; Desplanques L; Lévy-Bruhl D
    Arch Pediatr; 2010 Sep; 17(9):1281-7. PubMed ID: 20591630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of BCG vaccination on tuberculin surveys to estimate the annual risk of tuberculosis infection in south India.
    Gopi PG; Subramani R; Nataraj T; Narayanan PR
    Indian J Med Res; 2006 Jul; 124(1):71-6. PubMed ID: 16926459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Incidence of tuberculosis and a positive tuberculin test in children exposed to patients with tuberculosis. Importance of factors linked to the source and children despite previous vaccination with intradermal BCG].
    Morrone N; Solha MS
    AMB Rev Assoc Med Bras; 1983; 29(11-12):182-8. PubMed ID: 6608753
    [No Abstract]   [Full Text] [Related]  

  • 52. [BCG vaccination and antituberculosis measures in mass application].
    Mitinskaia LA; Lebedeva LV
    Probl Tuberk; 1972; 50(2):1-4. PubMed ID: 5016415
    [No Abstract]   [Full Text] [Related]  

  • 53. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
    Barreto ML; Pereira SM; Pilger D; Cruz AA; Cunha SS; Sant'Anna C; Ichihara MY; Genser B; Rodrigues LC
    Vaccine; 2011 Jul; 29(31):4875-7. PubMed ID: 21616115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011.
    Van Bui T; Lévy-Bruhl D; Che D; Antoine D; Jarlier V; Robert J
    Euro Surveill; 2015 Mar; 20(11):. PubMed ID: 25811645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
    Dierig A; Tebruegge M; Krivec U; Heininger U; Ritz N;
    Vaccine; 2015 Sep; 33(38):4994-9. PubMed ID: 26151543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Contemporary status of BCG vaccine in the world and in Serbia].
    Pesut D
    Med Pregl; 2004; 57 Suppl 1():37-40. PubMed ID: 15686220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Postvaccinal allergy and morbidity of tuberculosis in young children in peroral and intracutaneous BCG vaccination].
    Boris VM
    Probl Tuberk; 1967; 45(7):12-4. PubMed ID: 5605287
    [No Abstract]   [Full Text] [Related]  

  • 58. [Update on the BGC vaccine. Indications for use in Europe and in developing countries].
    Guerin N; Levy-Bruhl D
    Med Trop (Mars); 1996; 56(2):173-6. PubMed ID: 8926881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Causes of ineffectiveness of BCG vaccination and its impact on childhood tuberculosis].
    Ivan'kova VS; Ivanova NF
    Probl Tuberk; 1990; (9):20-1. PubMed ID: 2274500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.